Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Resectable Small Intestinal Carcinoma

Known as: Resectable Small Bowel Carcinoma, Small Intestine Carcinoma, Resectable, Resectable Carcinoma of the Small Intestine 
Carcinoma of the small intestine amendable to resection.
National Institutes of Health

Related topics

Related topics

12 relations
Abdominal PainCrohn DiseaseEpithelial CellsEpithelium
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus
Abstract The aim of the study was to determine the prognostic role of systemic immune-inflammation index (SII) in patients with… Expand
Is this relevant?
2015
2015
CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1
BackgroundCCR7 and MUC1 are correlated with lymph node metastasis in ESCC, but the role of MUC1 in the CCR7-induced lymphatic… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
Adoptive cell transfer after chemotherapy enhances survival in patients with resectable HNSCC.
OBJECTIVES The aims of this study were to evaluate the therapeutic efficacy and to determine the immune factors for treatment… Expand
Is this relevant?
2014
2014
Impact of Preoperative and Postoperative FOLFOX Chemotherapies in Patients with Resectable Colorectal Liver Metastasis
PurposeWhether the survival benefit of perioperative FOLFOX in patients with liver metastases of colorectal cancer (LMCRC) is… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2011
Review
2011
Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
BACKGROUND The standard treatment for resectable oesophageal squamous cell carcinoma (OSCC) is surgical resection with adequate… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
Low-Dose Preoperative Chemoradiation Therapy Compared with Surgery Alone with or Without Postoperative Radiotherapy in Patients with Head and Neck Carcinoma
BackgroundSeveral multimodal strategies have been developed to treat patients with squamous cell carcinoma of the oral cavity… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long…
PURPOSE The poor functional outcome in patients with advanced head and neck squamous cell carcinoma (HNSCC) with surgery and… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery
Background: Hepatocellular carcinoma (HCC) is a hypervascular malignancy. Vascular endothelial growth factor (VEGF), basic… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
PURPOSE To determine surgical resectability, event-free survival (EFS), and toxicity in children with hepatocellular carcinoma… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Prospective study of aggressive resection of metastatic pancreatic endocrine tumors.
BACKGROUND Because metastatic pancreatic endocrine tumors (MPET) have a poor prognosis, 17 patients with potentially resectable… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE